Last reviewed · How we verify

NCT04888559

Effects of a Whole Grain Cereal Product on Blood Glucose Response After 3 Consecutive Meals

Completed NA Last updated 29 June 2021
What this trial tests

NA trial testing Breakfast product: Whole grain in Blood Glucose in 10 participants. Completed in 15 June 2021.

Timeline
6 May 2021
Primary endpoint
15 June 2021
15 June 2021

Quick facts

Lead sponsorAventure AB
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingsingle
Primary purposeprevention
Enrollment10
Start date6 May 2021
Primary completion15 June 2021
Estimated completion15 June 2021
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Aventure AB

Who can join

Adults 35 to 65, any sex, with Blood Glucose. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this pilot study it will be investigated if a whole grain product will improve the glucose response not only when it is eaten at breakfast, but also at the two following meals; lunch and dinner (2nd and 3rd meal effect) in a healthy population.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Blood Glucose

Currently open trials in the same condition.

Other Aventure AB trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04888559.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing